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Abstract: In earlier studies, meniscal replacement with a porous polymer implant led to
regeneration of neo-meniscal tissue. To evaluate the inﬂuence of the chemical properties on the
tissue regeneration in the implant, in the present study, the meniscus in the dog’s knee was
replaced with either an aromatic 4,4-diphenylmethanediisocyanate based polyesterurethane
implant (Estane) (n  6) or with an aliphatic 1,4-butanediisocyanate based polyesterurethane
implant (PCLPU) (n  6). After 6 months, the knee joints were resected and the tissue
behavior in the two different prostheses was evaluated microscopically. In both prostheses, a
meniscus-like distribution of the tissue phenotype was found with collagen type I in the
peripheral ﬁbrous zones and collagen type II in the central, more cartilaginous zones. The
compression-stress behavior of the implant-tissue construct remained in between the stiffness
of the polymer material and that of the native meniscus. The PCLPU implant seemed to
provoke less synovial tissue reaction. After meniscectomy solely, in 5 out of 6 cases, a
meniscus-like regenerate was formed. Furthermore, the articular cartilage degeneration after
placing a PCLPU implant did also not exceed the degeneration after the Estane implant or
after meniscectomy. The differences between these two implants did not seem to inﬂuence the
tissue regeneration in the implant. However, PCLPU seemed to evoke less tissue reaction and,
therefore, is thought to be less or even nontoxic as compared with the Estane implant.
Therefore, for studies in the future, the authors prefer the PCLPU prostheses for replacement
of the meniscus. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 76B: 389–396,
2006
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INTRODUCTION
The menisci are C-shaped discs interposed between the fem-
oral condyles and tibial plateau and have the function of
shock absorption, stabilization, load distribution, and lubri-
cation of the knee joint. The meniscus contains ﬁbrochon-
drocytes, with an abundant extracellular matrix. The periph-
eral regions of the meniscus contain much collagen type I to
resist the tensile stresses. The central regions contain merely
type II collagen to resist compressive forces between the
femur and the tibia.1
Since the classical studies by Fairbank and King,2,3 it has
been recognized that meniscectomy leads to articular carti-
lage degeneration. Also, the degeneration of the cartilage
seemed proportional to the amount of tissue removed4 and
resection of lesions in the anterior and posterior horn had a
worse prognosis.5 Today, the method of choice is partial
meniscectomy to preserve as much meniscal tissue as possi-
ble. However, clinicians have noticed a high incidence of
arthritic changes in the joint in mid- and long-term outcome
studies of partial meniscectomy.6–9
In different animal models, several groups replaced the
meniscus with autologous materials like fat tissue,10,11 peri-
chondrium,12 and tendon.13 However, the poor initial me-
chanical characteristics resulted in poor outcomes. Our group
performed experiments in dogs and rabbits, using porous
polymer scaffolds for repair of lesions in the avascular part of
the meniscus,14–16 which showed that a fast inﬁltration of
ﬁbrous tissue into the polymer scaffold depends on the pres-
ence of interconnected macropores. Furthermore, a higher
stiffness (compression modulus) of the scaffold seemed to
stimulate the differentiation of ﬁbrous tissue into ﬁbrocarti-
lage.14 However, the Estane (an aromatic 4,4-diphenylmeth-
anediisocyanate based polyesterurethane) material used in
these studies contained an aromatic 4,4-diphenylmethane
compound that may degrade into toxic degradation products
Correspondence to: T. G. Tienen (e-mail: t.vantienen@orthop.umcn.nl)
© 2005 Wiley Periodicals, Inc.
389
after implantation. Also, a slower degradation pattern was
required to enable the tissue to inﬁltrate into the prosthesis
and to differentiate into new meniscal tissue, without losing
the biomechanical properties of the prosthesis. (Ramrattan et
al. publication in progress). Therefore, an aliphatic 1,4-bu-
tanediisocyanate based polyesterurethane (PCLPU) was de-
veloped.17 This material met with these requirements. In the
present study, the native meniscus of the dog was replaced
with either the PCLPU implant or an Estane implant. These
materials had a similar stiffness, porosity, and pore size. The
inﬁltrated tissue was analyzed histologically on synovial tis-
sue reaction, several extracellular matrix components, the
stiffness of the prosthesis explants, and ﬁnally, the conse-
quences for the articular cartilage degeneration were as-
sessed.
The hypothesis was that the PCLPU prosthesis enables a
similar tissue inﬁltration rate as the Estane based on the
comparable architecture and even less tissue reaction on the
material considering the lower degradation rate. In that case,




The Estane implants (5701-F1) (BF Goodrich Chemical N.V.
Westerlo-Oevel, Belgium) consisted of a hard segment of
4,4-methylenediphenyldiisocyanate. The content of hard seg-
ment mostly determines height of the compression modulus.
The soft segment is based on poly(tetramethyl adipate). The
porosity was 72.1%. This porosity was determined as fol-
lows. The mass of the polymer divided by the product of the
density of the polymer and the volume of the scaffold. Hun-
dred percent minus the amount of polymer results in the
porosity of the polymer. The compression modulus at 20%
compression was 260 kPa and the poresize 150–355 m. The
PCLPU polyurethanes consisted of a hard segment of 1,4-
butanediisocyanate and butanediol and a soft segment of
polycaprolactone initiated on 1,4-butanediol (PCL) with a
length of 1600 g/mol (Aldrich Chemical) (Figure 1). The
porosity of this material was 81.4%, the compression modu-
lus 290 kPa, and the poresize 150–355 m. Further charac-
teristics are described by Heijkants et al.18,19 The synthesis of
the Estane and PCLPU scaffolds were produced as described
elsewhere:20 the Estane and PCLPU were dissolved at 80°C
in either 1,4 dioxane and DMSO, respectively. Water was
added as a non solvent to induce the liquid–liquid phase
separation. Sucrose, 150–355 m, was added to the Estane
mixture to create the macropores in the scaffold. Then, the
mixture was frozen at –18°C during which the water/dioxane
was removed. The sucrose was washed out with water. In the
PCLPU fabrication process, sodium chloride crystals were
used instead of sucrose. Again, the scaffolds were washed
with water and eventually with ethanol to wash out the
DMSO. All pores were directly interconnected to achieve a
high permeability of both polymers (Figure 2).
Surgery
We performed a lateral meniscectomy on 18 legs of 18 adult
male and female Beagles. The average weight of the dogs was
13.2 kg (SD  2.6 kg). The institutional animal welfare com-
mittee approved all the procedures. Experiments were per-
formed under aseptic conditions. Anesthesia was accomplished
by intravenous administration of pentobarbital (30 mg/kg) and
maintained after intubation with nitrous oxide (1:1) and isoﬂu-
rane (0.5%). The knee joint was opened using a lateral skin
incision. The capsule was opened longitudinally and dissected
from the lateral attachment of the meniscus. We took great care
not to injure the collateral and cruciate ligaments and the artic-
ular cartilage. Using the Beaver eyeblade (Waltham, Massachu-
setts, USA) the meniscus was separated from its anterior and
posterior attachments. The prostheses were securely cut and
modeled from a porous polymer block to the shape of the
Figure 1. Chemical formulae of PCLPU and Estane.
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ectomized native meniscus during the surgical procedure. In six
knees, the meniscus was replaced by an Estane implant and in
six knees by a PCLPU implant. Two drill holes were made in the
lateral aspect of the proximal tibia, ending in the former anterior
and posterior origin of the meniscal horns. The Estane material
seemed to have a lower tear strength20 and therefore, it seemed
necessary to lead two bonded nondegradable sutures through the
Estane implant, parallel to the inner and outer rim (Figure 3). In
the PCLPU implant, however, the same sutures were pulled
trough the implants horns only, because of the higher tear
strength of this material. Further, the implantation procedures of
both implants were identical. Subsequently, the sutures were
pulled through the drill holes in the tibia. The periphery of the
implant was sutured to the peripheral knee joint capsule using
2–0 resorbable bonded sutures (Vicryl 2/0, Ethicon, Amersfoort
The Netherlands) to realize close contact between synovial tis-
sue and the meniscal implant. Afterwards, the capsule and skin
were closed. The dogs were allowed to walk as soon as possible.
Histology
After 6 months, dogs were killed and the polymer tissue
constructs were removed and ﬁxed in acetone (20°C) for
6 h, inﬁltrated in methylmethacrylate, and polymerized at
–20°C for 2 days. Sections (7 microns) were cut, dried at
37°C, and stained with Haematoxylin–Eosine and Toluidine
blue. In preparation for immunohistochemistry, sections were
deacrylated three times in chloroform–xylol (1:1) for 15 min
and subsequently treated with 1% testicular hyaluronidase
(type I-S, EC 3.2.1.35; Sigma, St. Louis, MO, USA) and in
PBS for 30 min at 37°C. To block nonspeciﬁc labeling,
sections were treated with 10% normal goat serum (for col-
lagen type I antibody labeling) and normal horse serum (for
collagen type II antibody labeling) in PBS with 1% bovine
serum albumin (Sigma, St. Louis, MO, USA). Monospeciﬁc
monoclonal rabbit anti-collagen type I antibody (PS-41, anti-
raised in rabbit, Sanbio, Uden, The Netherlands) and mouse
anti-collagen II antibody (II-II6B3, anti-chicken raised in
mouse, Developmental Studies Hybridoma bank, University
of Iowa, USA)21 were applied, and the samples were incu-
bated in a humidiﬁed chamber overnight at 4°C. Anti-colla-
gen antibodies were detected using a biotin-labeled anti-
rabbit antibody (1/200 dilution; Dako) and anti-mouse anti-
body (1/600 dilution; Dako) for 1 h at room temperature. A
biotin–streptavidin detection system (Vectra elite kit, Vector,
Burlingame, CA) was used according to the manufacturer’s
recommendations. The peroxidase was detected using tablets
containing 10 mg 3,3-diaminobenzidine tetrahydrochloride
(Sigma, St. Louis, MO, USA) dissolved in 15 mL PBS with
12 L H2O2 (30%) for 7 min. After rinsing, sections were
dehydrated and mounted with DPX (BDH, Poole, England).
Blocks of the complete tibial plateau and femoral condyles
were ﬁxed in a buffered formaldehyde solution (4%, pH 7.4)
for 2 days and rinsed, dehydrated, and embedded in methyl-
metacrylate for 2 days. The synovium biopsies were from the
most lateral area of directly next to the prosthesis. The
samples were ﬁxated in the same way.
Figure 3. Schematic presentation of the two operative procedures
for either the Estane implant and the PCLPU implant. After resection
of the native meniscus, two drill holes were created originating from
the lateral tibial side (A) to the former attachments of the anterior and
posterior horns of the native meniscus (B). In the Estane implant two
nonresorbable sutures were pulled longitudinally through the implant
(dotted lines) (C) and attached to the lateral proximal tibia. In the
PCLPU implant, the sutures were only pulled trough the horns. The
periphery of the implant was attached to the capsule with resorbable
sutures (D).
Figure 2. Scanning electron micrograph of the Estane (A) and PCLPU
(B) implant. Note similarity of the polymers and the interconnectivity of
the pores.
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Microscopy
On an ordinal scale, sections were scored for integration
between implant and capsule (percentage attachment) and
tissue inﬁltration into the implant (percentage of pores ﬁlled
with tissue). The amount of proteoglycan staining (percent-
age positive Toluidine blue staining on the total amount of
ingrown tissue) and collagen type I and II labeling (percent-
age positive antibody labeling on the total amount of ingrown
tissue) was determined by using the Quantimet 520 Image
Analysis System. The average percentage of positive staining
on the total amount of ingrown tissue was determined in two
sections through the center of the implant, with 200 microns
in between. Further, the phenotypes of the cells in the implant
were evaluated and classiﬁed as ﬁbrous, as cartilage-like, or
as a combination of both. The foreign body reaction in the
synovium and in the pores of the implant was scored accord-
ing to an ordinal scale as, no inﬂammation (grade 0), slight
inﬂammation (few macrophages/giant cells; grade 1), well
deﬁned inﬂammatory reaction (many macrophages/giant
cells, no PMN leucocytes; grade 2), moderate inﬂammation
(many macrophages/giant cells with few PMN leucocytes;
grade 3), and severe inﬂammation (abundant macrophages,
giant cells and PMN leucocytes; grade 4).16
Degenerative articular changes were scored according to
the Mankin grading system, from normal structure (grade 0)
to complete disorganization (grade 6), normal cells (grade 0)
to hypocellularity (grade 6), normal Toluidine Blue staining
(grade 0) to no staining (grade 4), and an intact tidemark
(grade 0) or a tidemark inﬁltrated with blood vessels (grade
1).22 The total score of each subcategory determined the
Mankin score. The observer was blinded for the treatment.
After excision of the polymer-tissue construct from the
dog’s knee, 4 mm biopsies were punched out from 5 out of
the 6 explanted menisci/implants. These were taken from a
speciﬁed region of the posterior horn of both the implants, as
from the native meniscus. Also, biopsies were taken from the
porous polymer before implantation. Nonconﬁned compres-
sion testing was performed on the cylinder shaped specimens
in saline at room temperature, using an Instron (4301) com-
pression tester, equipped with a 100 N load cell. A compres-
sion rate of 2 mm/min was applied.
Differences in cartilage degeneration were statistically
evaluated by using the Kruskal–Wallis one way analysis of
variance of ranks (ANOVA). Differences in tissue reaction
between the two prostheses were evaluated using the Mann–
Whitney rank sum test. p-Values were calculated, and values
of less than 0.05 were considered to be signiﬁcant.
RESULTS
The dogs had regained their normal gait pattern 14 days
postoperatively. No infections were seen. All meniscecto-
mized knees and knees with implant were available for eval-
uation. Postmortem analysis showed no signs of synovitis,
and the synovial ﬂuid was clear.
Macroscopically, both the Estane group as well as the
PCLPU prostheses were completely integrated with the pe-
ripheral capsule and the prosthetic horns were ﬁrmly attached
to the tibial plateau. All prostheses seemed to be completely
covered by a transparent layer. In both the Estane group (3
cases) as well as the PCLPU implant group (4 cases), the
popliteus tendon seemed to have entered the joint space and
damaged the polymer implants. Macroscopically, it could not
be determined if this interpolating tendon also damaged the
articular cartilage.
In the group with meniscectomy solely, in 5 out of 6 cases
tissue had formed in between instead of the resected menis-
cus. This tissue resembled the native meniscal tissue. How-
ever, the tissue was more ﬂexible and softer than native
meniscal tissue.
Most of the samples still have to be analyzed, but prelim-
inary histological analysis only showed ﬁbrous scar tissue
instead of the ﬁbrocartilage that is observed in native menis-
cal tissue.
Microscopically, the Estane prostheses and the PCLPU
prostheses were completely inﬁltrated with tissue and cov-
ered the whole prosthetic surface with a thin tissue layer.
In the PCLPU prostheses, small pores several microns in
size were also observed, which were connected with the
macropores and ﬁlled with a-cellular ﬁbrin. These pores
were not observed in the Estane prostheses. Only mechan-
ical damage to the prosthesis seemed to have occurred as
a result of the popliteus tendon entering the joint space. In
none of the prostheses the degradation of the material had
already started.
In all cases, the tissue in the peripheral areas of the
prostheses had a ﬁbrous phenotype, with an abundant extra-
cellular matrix [Figure 4(A)]. The extracellular matrix in
these areas contained many ﬁber bundles, which also pene-
trated the connections between the pores [Figure 4(B)]. These
bundles positively stained with collagen type I antibodies. In
5 cases in the Estane group and in 4 cases in the PCLPU
group, the tissue in areas near the inner rim of the prostheses
showed less collagen type I antibody labeling than in the
peripheral zones. The cells in these areas had a cartilaginous
phenotype. The round cells were lying in their lacunae and
were surrounded by an abundant extracellular matrix, which
showed less H&E staining and evident positive Toluidine
Blue staining. These areas of positive Toluidine Blue staining
exactly matched with the areas of positive collagen type II
antibody labeling in the adjacent sections [Figures 4(C,D)].
The inﬂammatory reaction within the Estane implant did
not differ from the reaction in the PCLPU implant. A slight
inﬂammatory reaction was present in the pores, with scarce
macrophages and giant cells. These cells were organized in
close contact with the surface of the polymer. However,
particles of the polymer in the macrophages could not be
observed. PMN leucocytes were absent. In the synovium,
however, the tissue adjacent to the Estane implant showed
signiﬁcantly more macrophages and giant cells than the tissue
near the PCLPU implant (p  0.041). In all Estane explants,
the synovium scored a grade 2 reaction. In the PCLPU
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prosthesis the synovium scored only two times grade 2 and
the other four samples scored grade 1. Despite the difference
in tissue reaction, the tissue reaction near both implants never
exceeded grade 2 (many macrophages/giant cells, no PMN
leucocytes). Luxation of the popliteus tendon into the joint
space seemed not to have inﬂuenced the degree of tissue
reaction.
At gross inspection, both in the groups with prostheses as
well as in the meniscectomy group, the damage of the carti-
lage varied from an intact surface layer to degenerative le-
Figure 4. Micrographs of sections of an Estane implant (left column) and a PCLPU implant (right
column) 6 months after implantation. (A) Implant labeled with collagen type I antibodies. Note
abundant staining in the peripheral regions of the meniscus and less labeling near the inner rim
(arrowheads) 4. (B) Magniﬁcation of a region in the peripheral zone of the implant. Tissue with many
blood vessels (arrows) and intensive labeling of the collagen bundles (arrowheads). Collagen type I
antibody labeling, 100. (C and D) Adjacent sections of tissue near the inner rim of the implant. Note
the cartilage-like phenotype of the cells and the abundant collagen type II antibody labeling (C) and
Toluidine blue (TB) staining (D) of their matrix. 100.
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sions. Neither meniscectomy nor implantation of an implant
resulted in osteophyte formation.
The cartilage degeneration could be conﬁrmed microscop-
ically. The tibial cartilage lesions were merely localized ad-
jacent to the inner rim of the implant the tibial lesions after
meniscectomy were spread over a greater area, whereas on
the femoral side, the degeneration had spread over a more
broad area at the dorsal curvature of the condyle, both in the
meniscectomy and in the implant groups. (Figure 5). Degen-
erated areas showed varying degrees of surface ﬁbrillation,
cloning of the cells, and decreased Toluidine Blue staining.
The subchondral bone was never exposed in either of the
groups.
In dogs with an implant, more degeneration tended to
occur at the tibial side than at the femoral side. In the
meniscectomy group, the degeneration on these sides was
comparable. In both groups with an implant, the tibial carti-
lage was more damaged than that at the femoral side, al-
though the Mankin scores were not signiﬁcantly different.
After meniscectomy, this difference was not observed. The
Mankin score did not signiﬁcantly differ among the three
groups (p  0.124).
Six months after implantation, the Estane implant showed
approximately similar compression curve as the PCLPU im-
plant. In both the Estane prostheses as well as the PCLPU
prostheses, the slopes of the compression curve evidently
increased from implantation to 6 months follow-up (Figure 6).
DISCUSSION
In the present study, the meniscus was replaced with a porous
polymer implant in the dog’s knee. In earlier studies, the ideal
pore sizes for a fast inﬁltration of tissue seemed to be in the
range of 150–500 um.15 This was conﬁrmed in the present
study, in which both implants contained directly interconnected
macropores in the range of 150–355 m and showed complete
tissue inﬁltration within 3 months after implantation. Consider-
ing that the cartilage-like tissue formation seemed to increase
with a higher initial compression modulus of the scaffold,14 new
prostheses were developed, with a higher compression modulus.
This may have led to the location speciﬁc phenotypical differ-
entiation of the ingrown tissue.
One of the differences between the two prosthetic mate-
rials is the degree of phase separation between the hard and
soft segment. The PCLPU polymer seemed to be more phase-
separated than the Estane polymer. The hydrophobic segment
of the polymer is mainly located in the periphery of the
implant where in the Estane polymer, the phase separation is
less, resulting in a greater exposure of the more hydrophilic
elements of the polymer,23 which again might play an im-
portant role in the cell attachment.24 However, the differences
between the two prostheses seemed to be too small to evoke
a difference in tissue inﬁltration. The difference might even
be smaller when the implant becomes ﬁlled with blood, and
a layer of proteins will be deposited on the implant surface.
Several blood proteins seemed to intermediate between the
cells and the polymer surface and this process should increase
the cell afﬁnity to the polymer.25 The porous structures were
made using a different method, which might have an effect on
amount solvent that remains in the implant after washing.
Compared to the DMSO solvent the dioxane is a more harm-
ful solvent for the cells. Nevertheless, the difference in sol-
vent did not play an important role in the tissue ingrowth.
Another important difference between the two prosthetic
materials consists in the presence of an aromatic 4,4-diphe-
nylmethane compound in the Estane polymer. This is impor-
tant in the degradation phase of the material. The aromatic
4,4-diphenylmethane diisocyanate (MDI) may be converted
into the toxic and carcinogenic methylenedianiline after deg-
radation.26 The aliphatic PCLPU prostheses, however, con-
tains butanediisoccyanate (BDI) instead, which degrades into
1,4-diaminobutane upon degradation. This is also known as
putrescine, which is suggested to act as a growth factor for
mammalian cells.27,28
The reaction of the host to the polymers remained re-
stricted to macrophages and multinucleated giant cells
(MNGC’s). Polymorphonuclear leucocytes were never ob-
served. Nevertheless, the amount of macrophages and
MNGC’s was higher in the synovium near the Estane im-
plant, than in the synovium near the PCLPU implant. The
higher recruitment of cells may be due to the difference in
chemical composition between the prostheses or may also be
a result of degradation of the Estane implant and the exposure
of the tissue to the degradation products. As stated in an
earlier study, the Estane seemed to be degraded after 40
weeks, while the PCLPU material remains in situ longer than
a year.20 The macrophages and giant cells may also exhibit a
higher afﬁnity for the Estane degradation products than for
the products of the PCLPU implant. Currently, studies are
being performed for further evaluation of the differences in
tissue–host reaction between the two polymers. In a former
study, the amount of MNGC’s seemed higher, which contrib-
uted to the relatively large amount of small pores in the
polymer.29 In the present study, polymers were used with
macropores only (155–355 microns), which might be respon-
sible for the relatively low recruitment of these cells, as
Figure 5. Articular cartilage degeneration according to the Mankin
score. The cartilage degeneration in the meniscectomy group is sig-
niﬁcantly less than in the PCLPU implant group.
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described in a study by White et al.30 When cells are not able
to inﬁltrate and integrate the material, in case of small pores,
reaction cells are recruited to phagocyte the material.
Meniscal ﬁbrocartilage is described as a tissue containing
ﬁbrochondrocytes, which are surrounded by an abundant
extracellular matrix.31–33 The collagen type I in native pe-
ripheral meniscal tissue provides the circumferential tensile
strength to resist the hoop stresses during loading of the
joint.34 The collagen type II is able to resist compressive
forces and, therefore, is merely found in the central rim of the
meniscus where the force transduction between the femur and
tibia is highest.35 In the present study, the similarity of
location speciﬁc differentiation of tissue between the native
meniscus and the implant could suggest that the implant
approached the functional behavior of the native meniscus in
the knee joint. However, the high anisotropic orientation of
the collagen type I ﬁbers, which is observed in the native
meniscus36 was not observed in the implant. The authors
expect that during degradation of the implant, the amount of
collagen type I bundles and their orientation will further
adjust under inﬂuence of the load in the knee joint.
Especially in the role of stabilization and alignment of the
knee joint, a high compression modulus is important to resist
the high loading forces and to distribute these loads over a
greater surface.36 In this study, the compression curves of the
two prostheses did not differ and approached that of the
native meniscus. How these curves will develop during deg-
radation of the polymer, remained to be determined. The
degradation of the Estane starts earlier and proved to have a
higher degradation rate than the PCLPU polymer20 and con-
sequently will faster loose its biomechanical properties.
Therefore, over time, the stiffness of the implant-tissue con-
struct will progressively depend on the characteristics of the
ingrown tissue rather than on the prosthetic material. Ideally,
a perfect balance exists between polymer degradation rate
and maturation of the tissue so as to maintain the material
stiffness. The authors speculate that the polymer should retain
its biomechanical characteristics for at least 1 year to enable
the tissue to complete the maturation process.
In the present study, both the Estane implant as well as the
PCLPU implant induced articular cartilage degeneration.
More degeneration was seen on the tibia than on the femur.
During knee joint ﬂexion, the femur rolls over the meniscus
while the meniscus glides backwards over the tibia. The latter
movement may have caused higher stresses on the cartilage.
The exact cause for the degeneration could not be deter-
mined. In our laboratory, the dog used for animal experiments
is the Beagle, which has relatively small knee joints. This
makes the trauma after resection of the meniscus alone rela-
tively lower than after replacement of the implant. This might
have played a role in the degeneration process. In the human
situation, the joint is much bigger, which makes the surgery
easier. Probably, there is an arthroscopic way for implanta-
tion of the prosthesis, which also might lead to less damage
to the knee joint. Next experiments will be performed in
bigger animals to resolve this problem. Another explanation
might be material characteristics of the implant, which had a
relatively rough polymer surface. The prostheses were se-
curely cut and modeled from a porous polymer block to the
shape of the ectomized native meniscus, during the surgical
procedure. Nevertheless, scanning electronic microscopical
examination of the prosthetic surface revealed the inevitable
irregularities on the prosthetic surface. Producing these pros-
theses with a mold may provide scaffolds with a smooth
surface and with the required standard form. Furthermore, in
an earlier study we observed that the degeneration did not
increase from 3 to 6 months (unpublished results). Degener-
ation might have taken place merely during the ﬁrst months
while the prosthetic surface, not covered with tissue, was in
direct contact with the articular cartilage. A tissue layer
between the polymer material and the articular cartilage
might have more gliding capacity than the bare polymer
surface itself. Seeding autologous meniscal cells in the im-
plant previous to the implantation procedure might solve this
problem. In this way, the cells are able to produce their
extracellular matrix so that the polymer surface will be cov-
ered with a tissue layer at the time of implantation.
In the meniscectomy group, a meniscus like regenerate
was observed, which also might have protected the articular
cartilage from damage. However, the tissue had a ﬁbrous
appearance and seemed less stiff than native meniscal tissue.
A more detailed characterization of this tissue is being per-
formed at this moment.
A popliteus tendon that enters the knee joint space might
also contribute to the cartilage degeneration. During surgery,
a vertical arthrotomy is performed and the dorsal ﬂap is
completely mobilized to obtain exposure of the knee joint. By
dissecting the dorsal ﬂap from the tibia and meniscus, the
tendon sheet of the popliteus tendon might have been dam-
aged, which eventually led to loosening of the tendon from
the periphery. Probably, the implant and the cartilage were
damaged by the popliteus tendon lying in the knee joint. In
future studies, we need to limit the dissection in the dorsal to
prevent dissection of the tendon sheet.
Figure 6. Average compression-stress curves of samples from the
posterior horn of the prosthetic material before implantation (A) and
after 3 months (B) and 6 months (C) follow up.
395MENISCAL REPLACEMENT WITH TWO DIFFERENT POROUS POLYMER PROSTHESES
In conclusion, implantation of these prostheses led to fast
inﬁltration of tissue and differentiation into cartilage-like
tissue. In both prostheses, a meniscus-like distribution of the
tissue phenotype was found. Also, the stiffness of the im-
plant-tissue construct approached that of the native meniscus.
Furthermore, neither implant in its current shape could pre-
vent articular cartilage degeneration. Further improvements
to the prostheses might change this ﬁnding.
Even though both prostheses seemed suitable for tissue
regeneration, the PCLPU implant had some advantages over
the Estane implant. Firstly, the PCLPU is thought to be less
or even nontoxic as compared with the Estane implant. Fur-
thermore, the PCLPU implant seemed to provoke a less
synovial tissue reaction.
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